-
Advertisement
Asean
This Week in AsiaEconomics

Asean hopes to sway US on trade tariffs but it’s not looking promising

Trade Representative Jamieson Greer has indicated that the US will not be backing down on its demands

Reading Time:3 minutes
Why you can trust SCMP
3
US Trade Representative Jamieson Greer delivers opening remarks during the Asean Economic Ministers’ Meeting in Kuala Lumpur on Wednesday. Photo: Reuters
Joseph Sipalan
Efforts this week by Asean nations to water down Washington’s tariffs through talks with the US’ point man on trade appear to have failed, experts say. Instead, fresh threats were issued of levies unless lopsided trade deals favouring America can be quickly reached.
During a two-day visit to Kuala Lumpur that began on Wednesday, US Trade Representative Jamieson Greer made it clear that Washington would not budge on its goal of reclaiming control of key industries – including semiconductors, which are also vital to Malaysia, Vietnam and Thailand.

While he acknowledged that members of the Association of Southeast Asian Nations were key cogs in the global semiconductor supply chain, he said chips were “critical” to US national security, signalling there would be no backtracking on reshoring the semiconductor manufacture to the US.

Advertisement
Greer’s big stick approach sets the tone for US President Donald Trump’s highly anticipated visit to Kuala Lumpur next month to attend the Asean summit, experts say, where leaders of the region’s export-led economies had hoped he would hear their pleas for freer access to the world’s largest consumer market.

The trade representative’s position on semiconductors came just hours before Trump announced a 100 per cent tariff on imported pharmaceuticals effective from next Wednesday.

Southeast Asian trade ministers chat at the 57th Asean Economic Ministers’ Meeting in Kuala Lumpur on Tuesday. Photo: Reuters
Southeast Asian trade ministers chat at the 57th Asean Economic Ministers’ Meeting in Kuala Lumpur on Tuesday. Photo: Reuters

This could potentially blindside a bloc whose key members make generic drugs and ingredients for vaccines and patented drugs – and who also could face surging medical costs if forced to buy from the US.

Advertisement
Select Voice
Select Speed
1.00x